Zimmer Biomet Inspection Finds Extensive GMP Woes

The document cites a range of issues that could tie to product safety, such as water and air quality, and maintenance of a sterile work environment. But the company says it is working with US FDA on its remediation plan and states that no known product safety issues are linked to the observations.

More from Regulation

More from Policy & Regulation